Related references
Note: Only part of the references are listed.18F-Fluorodihydroxyphenylalanine PET/CT in Patients with Neuroendocrine Tumors of Unknown Origin: Relation to Tumor Origin and Differentiation
Alessio Imperiale et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
A Case of Insulinoma Detected by 68Ga-DOTANOC PET/CT and Missed by 18F-Dihydroxyphenylalanine PET/CT
Giorgio Treglia et al.
CLINICAL NUCLEAR MEDICINE (2013)
Added value of early 18F-FDOPA PET/CT acquisition time in medullary thyroid cancer
Michael Soussan et al.
NUCLEAR MEDICINE COMMUNICATIONS (2012)
Glucagon-Like Peptide-1 Versus Somatostatin Receptor Targeting Reveals 2 Distinct Forms of Malignant Insulinomas
Damian Wild et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Clinical PET Imaging of Insulinoma and Beta-Cell Hyperplasia
S. Kauhanen et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET
Maarten Brom et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Limited Value of 18F-F-DOPA PET to Localize Pancreatic Insulin-Secreting Tumors in Adults with Hyperinsulinemic Hypoglycemia
L. Tessonnier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Glucagon-Like Peptide-1 Receptor Imaging for Localization of Insulinomas
Emanuel Christ et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline
Philip E. Cryer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Localization of Insulinomas to Regions of the Pancreas by Intraarterial Calcium Stimulation: The NIH Experience
Jean-Marc Guettier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Somatostatin Receptor Imaging with In-111-Pentetreotide
Dik J. Kwekkeboom et al.
NEUROENDOCRINOLOGY (2009)
Manipulation of [11C]-5-hydroxytryptophan and 6-[18F]fluoro-3,4-dihydroxy-L-phenylalanine accumulation in neuroendocrine tumor cells
Oliver C. Neels et al.
CANCER RESEARCH (2008)
Evaluation of [18F]Fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism
Winfried Barthlen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Premedication With Carbidopa Masks Positive Finding of Insulinoma and β-Cell Hyperplasia in [18F]-Dihydroxy-Phenyl-Alanine Positron Emission Tomography
Saila Kauhanen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography
Klaas P. Koopmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
18F-Dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer:: Relation to tumor differentiation
Klaas P. Koopmans et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Glucagon-like peptide 1-receptor scans to localize occult insulinomas
Damian Wild et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy:: a retrospective study involving 49 children
Maria-Joao Ribeiro et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
The effects of carbidopa on uptake of 6-18F-fluoro-L-DOPA in PET of pheochromocytorna and extraadrenal abdominal paraganglioma
Henri J. L. M. Timmers et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma
B. Beuthien-Baumann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or β-cell hyperplasia in adult patients
Saila Kauhanen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Diagnosis and localization of focal congenital hyperinsulinism by 18F-Fluorodopa PET scan
Olga T. Hardy et al.
JOURNAL OF PEDIATRICS (2007)
Staging of carcinoid tumours with 18F-DOPA PET:: a prospective, diagnostic accuracy study
Klaas P. Koopmans et al.
LANCET ONCOLOGY (2006)
Congenital hyperinsulinism:: Pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion
P de Lonlay et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with C-11-5-hydroxytryptophan positron emission tomography
H Orlefors et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Noninvasive diagnosis of focal hyperinsulinism of infancy with [F-18]-DOPA positron emission tomography
T Otonkoski et al.
DIABETES (2006)
Insulinoma
CS Grant
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2005)
The diagnosis and medical management of advanced neuroendocrine tumors
GA Kaltsas et al.
ENDOCRINE REVIEWS (2004)
Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting
JC Reubi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors
S Hoegerle et al.
RADIOLOGY (2001)
Share Paper
